Jake Olin

Jake Olin has a diverse work experience in business development and research. Jake is currently working as the Sr. Director of Business Development at Orna Therapeutics since April 2022. Prior to that, they worked at Biogen as a Director from June 2020 to April 2022. Before Biogen, Jake held various roles at Pfizer, including Director from December 2018 to June 2020, Sr. Manager, Oncology BD from November 2017 to November 2018, and Manager, Business Development from October 2016 to October 2017. Jake also worked as a Corporate Development Manager at Teleflex Incorporated from May 2014 to October 2016 and as a Consulting Associate at Charles River Associates from September 2013 to May 2014. Jake's work experience also includes a consultant role at Leerink Swann from December 2009 to 2013, an analyst role at Leerink Swann from July 2008 to August 2009, and research positions at Predictive Biosciences, Critical Therapeutics, and Harvard Medical School. At Harvard Medical School, Jake worked as a Research Assistant in Dr. Lawrence Cohn's cardiac research laboratory, where they conducted research on cancer spread in the lymphatic system.

Jake Olin attended The Rivers School from 2000 to 2004. Jake then pursued a Bachelor's degree in Economics and Pre-Medicine at New York University from 2004 to 2008.